 CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 19, 2022 GLOBE NEWSWIRE -- Centogene N.V. Nasdaq: CNTG, the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced that Company management will present in the virtual track at the H.C. Wainwright Global Investment Conference being held May 2326, 2022, and invites investors to participate via virtual one-on-one meetings. 